Anson Funds Management LP - Q4 2016 holdings

$320 Million is the total value of Anson Funds Management LP's 88 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was 156.1% .

 Value Shares↓ Weighting
AMZN SellAMAZON COM INCput$44,992,000
-50.7%
60,000
-45.0%
14.07%
+43.5%
SPY BuySPDR S&P 500 ETF TRtr unit$28,819,000
+96.4%
128,925
+90.0%
9.02%
+471.7%
NewBROADCOM LTDput$27,399,000155,000
+100.0%
8.57%
BAC SellBANK AMER CORP$26,927,000
-67.0%
1,218,425
-76.7%
8.42%
-4.1%
BXE SellBELLATRIX EXPLORATION LTD$23,040,000
-16.8%
18,000,000
-26.5%
7.21%
+142.3%
MSFT SellMICROSOFT CORP$19,872,000
-46.1%
319,787
-50.0%
6.22%
+57.0%
IBM NewINTERNATIONAL BUSINESS MACHSput$13,279,00080,000
+100.0%
4.15%
VMC SellVULCAN MATLS CO$10,488,000
-45.0%
83,800
-50.0%
3.28%
+60.1%
NewCIRRUS LOGIC INCput$10,262,000181,500
+100.0%
3.21%
PERY SellELLIS PERRY INTL INC$9,660,000
-48.6%
387,790
-60.3%
3.02%
+49.5%
EVC SellENTRAVISION COMMUNICATIONS Ccl a$8,645,000
-55.7%
1,235,000
-51.8%
2.70%
+28.8%
DXJ SellWISDOMTREE TRjapn hedge eqt$8,174,000
-42.3%
165,000
-50.0%
2.56%
+68.0%
MSI NewMOTOROLA SOLUTIONS INCput$8,007,00096,600
+100.0%
2.50%
NewSKYWORKS SOLUTIONS INCput$7,466,000100,000
+100.0%
2.34%
NewROYAL BK CDA MONTREAL QUEput$7,448,000110,000
+100.0%
2.33%
TK SellTEEKAY CORPORATION$6,132,000
-65.8%
763,597
-67.2%
1.92%
-0.5%
GOLD SellRANDGOLD RES LTDadr$5,230,000
-61.9%
68,504
-50.0%
1.64%
+11.1%
CAT NewCATERPILLAR INC DEL$4,637,00050,000
+100.0%
1.45%
STKS SellTHE ONE GROUP HOSPITALITY IN$3,838,000
-60.6%
1,728,915
-55.6%
1.20%
+14.8%
DD BuyDU PONT E I DE NEMOURS & CO$3,670,000
+37.0%
50,000
+25.0%
1.15%
+298.6%
NewINTEL CORPput$3,627,000100,000
+100.0%
1.14%
JPM SellJPMORGAN CHASE & CO$2,589,000
-35.2%
30,000
-50.0%
0.81%
+88.8%
MBT SellMOBILE TELESYSTEMS PJSCsponsored adr$2,062,000
-40.3%
226,292
-50.0%
0.64%
+73.9%
ANCB SellANCHOR BANCORP WA$2,029,000
+5.7%
74,603
-0.9%
0.64%
+208.3%
MEIP NewMEI PHARMA INC$1,968,0001,366,859
+100.0%
0.62%
SERV SellSERVICEMASTER GLOBAL HLDGS I$1,884,000
-44.1%
50,000
-50.0%
0.59%
+62.7%
CEF SellCENTRAL FD CDA LTDcl a$1,355,000
-59.2%
120,000
-50.0%
0.42%
+18.8%
HIHO NewHIGHWAY HLDGS LTDord$1,273,000618,702
+100.0%
0.40%
XXII New22ND CENTY GROUP INC$1,178,0001,080,750
+100.0%
0.37%
POT SellPOTASH CORP SASK INC$1,176,000
-44.6%
65,000
-50.0%
0.37%
+61.4%
NOVN NewNOVAN INC$1,107,00040,986
+100.0%
0.35%
QRVO SellQORVO INCput$1,055,000
-78.9%
20,000
-77.7%
0.33%
-38.5%
SNOAW NewSONOMA PHARMACEUTICALS INC*w exp 01/21/202$1,018,000202,014
+100.0%
0.32%
CASC NewCASCADIAN THERAPEUTICS INC$988,000229,286
+100.0%
0.31%
ALDW NewALON USA PARTNERS LPut ltdpart int$960,000100,000
+100.0%
0.30%
CMG SellCHIPOTLE MEXICAN GRILL INC$868,000
-55.4%
2,300
-50.0%
0.27%
+30.1%
AUPH NewAURINIA PHARMACEUTICALS INC$815,000388,008
+100.0%
0.26%
RNN SellREXAHN PHARMACEUTICALS INC$768,000
-80.1%
5,409,500
-70.5%
0.24%
-42.0%
NXTDW SellNXT ID INC*w exp 02/09/201$742,000
-54.5%
269,900
-50.0%
0.23%
+32.6%
HEB SellHEMISPHERX BIOPHARMA INC$739,000
-77.7%
1,071,627
-59.2%
0.23%
-35.1%
AFMD SellAFFIMED N V$654,000
-67.6%
363,161
-50.0%
0.20%
-5.5%
OVAS NewOVASCIENCE INC$637,000416,297
+100.0%
0.20%
ARWR NewARROWHEAD PHARMACEUTICALS IN$548,000353,428
+100.0%
0.17%
CVRR NewCVR REFNG LP$520,00050,000
+100.0%
0.16%
NVLS NewNIVALIS THERAPEUTICS INC$422,000188,287
+100.0%
0.13%
ADAP NewADAPTIMMUNE THERAPEUTICS PLCsponds adr$418,000103,282
+100.0%
0.13%
CHMA NewCHIASMA INC$400,000205,380
+100.0%
0.12%
VSTM NewVERASTEM INC$386,000344,443
+100.0%
0.12%
ADVM NewADVERUM BIOTECHNOLOGIES INC$373,000128,539
+100.0%
0.12%
APOPW NewCELLECT BIOTECHNOLOGY LTD*w exp 07/28/202$350,000113,347
+100.0%
0.11%
CBMXW SellCOMBIMATRIX CORPORATION*w exp 03/18/202$327,000
-71.2%
123,238
-54.1%
0.10%
-16.4%
SGMO NewSANGAMO BIOSCIENCES INC$306,000100,209
+100.0%
0.10%
IZEA NewIZEA INC$301,00066,734
+100.0%
0.09%
ADHD NewALCOBRA LTD$300,000142,973
+100.0%
0.09%
TUESQ NewTUESDAY MORNING CORP$295,00054,611
+100.0%
0.09%
DRNA NewDICERNA PHARMACEUTICALS INC$287,00099,658
+100.0%
0.09%
CAPN NewCAPNIA INC$288,000355,497
+100.0%
0.09%
REFR NewRESEARCH FRONTIERS INC$289,000158,937
+100.0%
0.09%
NVTRQ NewNUVECTRA CORP$283,00056,253
+100.0%
0.09%
ONCS NewONCOSEC MED INC$280,000227,293
+100.0%
0.09%
ORPN NewBIOBLAST PHARMA LTD$282,000270,793
+100.0%
0.09%
AEZS NewAETERNA ZENTARIS INC$275,00056,800
+100.0%
0.09%
ECYT NewENDOCYTE INC$276,000108,426
+100.0%
0.09%
VTL NewVITAL THERAPIES INC$270,00062,137
+100.0%
0.08%
APDN NewAPPLIED DNA SCIENCES INC$266,000143,838
+100.0%
0.08%
PTIE NewPAIN THERAPEUTICS INC$262,000459,667
+100.0%
0.08%
APRI NewAPRICUS BIOSCIENCES INC$263,000202,475
+100.0%
0.08%
PPLT SellETFS PLATINUM TRsh ben int$259,000
-56.2%
3,000
-50.0%
0.08%
+26.6%
ABUS NewARBUTUS BIOPHARMA CORP$257,000105,085
+100.0%
0.08%
LOV NewSPARK NETWORKS INC$251,000299,107
+100.0%
0.08%
UQM NewUQM TECHNOLOGIES INC$243,000565,204
+100.0%
0.08%
IMUCW NewIMMUNOCELLULAR THERAPEUTICS*w exp 08/12/202$240,000117,188
+100.0%
0.08%
ISR NewISORAY INC$235,000404,895
+100.0%
0.07%
PSDV NewPSIVIDA CORP$225,000131,463
+100.0%
0.07%
SBBP NewSTRONGBRIDGE BIOPHARMA PLC$221,00092,219
+100.0%
0.07%
ONTXW NewONCONOVA THERAPEUTICS INC*w exp 07/07/202$213,00093,750
+100.0%
0.07%
MDM SellMOUNTAIN PROV DIAMONDS INC$213,000
-50.9%
31,700
-50.0%
0.07%
+42.6%
STLY NewSTANLEY FURNITURE CO INC$212,000235,047
+100.0%
0.07%
CTHR NewCHARLES & COLVARD LTD$203,000184,742
+100.0%
0.06%
CLSN NewCELSION CORPORATION$200,000657,890
+100.0%
0.06%
RFIL NewRF INDS LTD$191,000109,234
+100.0%
0.06%
FTEK NewFUEL TECH INC$165,000143,845
+100.0%
0.05%
INVT NewINVENTERGY GLOBAL INC$154,000205,149
+100.0%
0.05%
NBRV NewNABRIVA THERAPEUTICS AGsponsored adr$155,00026,029
+100.0%
0.05%
JAGX NewJAGUAR ANIMAL HEALTH INC$135,000188,200
+100.0%
0.04%
EGT NewENTERTAINMENT GAMING ASIA IN$72,00051,831
+100.0%
0.02%
EYES NewSECOND SIGHT MED PRODS INC$61,00031,097
+100.0%
0.02%
CPSH NewCPS TECHNOLOGIES CORP$36,00019,506
+100.0%
0.01%
BPMX ExitBIOPHARMX CORP$0-411,918
-100.0%
-0.02%
GNVC ExitGENVEC INC$0-660,412
-100.0%
-0.03%
DSKX ExitDS HEALTHCARE GROUP INC$0-2,379,200
-100.0%
-0.06%
CVM ExitCEL SCI CORP$0-2,011,024
-100.0%
-0.07%
UUUU ExitENERGY FUELS INC$0-462,136
-100.0%
-0.08%
C ExitCITIGROUP INC$0-20,000
-100.0%
-0.10%
CGIX ExitCANCER GENETICS INC$0-543,444
-100.0%
-0.10%
IMUCWS ExitIMMUNOCELLULAR THERAPEUTICS*w exp 08/12/202$0-9,375,000
-100.0%
-0.12%
QTM ExitQUANTUM CORP$0-2,413,448
-100.0%
-0.19%
CYTXW ExitCYTORI THERAPEUTICS INC*w exp 12/09/201$0-900,000
-100.0%
-0.20%
TBBK ExitBANCORP INC DEL$0-75,251
-100.0%
-0.21%
CASC ExitCASCADIAN THERAPEUTICS INC$0-1,275,400
-100.0%
-0.22%
OCLSW ExitOCULUS INNOVATIVE SCIENCES I*w exp 01/21/202$0-532,726
-100.0%
-0.25%
SBOT ExitSTELLAR BIOTECHNOLOGIES INC$0-1,426,612
-100.0%
-0.37%
APRI ExitAPRICUS BIOSCIENCES INC$0-10,185,160
-100.0%
-0.37%
AMD ExitADVANCED MICRO DEVICES INCput$0-600,000
-100.0%
-0.45%
TXN ExitTEXAS INSTRS INCput$0-71,200
-100.0%
-0.54%
ADI ExitANALOG DEVICES INCput$0-110,000
-100.0%
-0.76%
CRM ExitSALESFORCE COM INCput$0-100,000
-100.0%
-0.77%
C ExitCITIGROUP INCcall$0-191,600
-100.0%
-0.97%
RY ExitROYAL BK CDA MONTREAL QUEput$0-220,000
-100.0%
-1.46%
CXW ExitCORRECTIONS CORP AMER NEW$0-1,014,206
-100.0%
-1.51%
NVDA ExitNVIDIA CORPput$0-229,200
-100.0%
-1.69%
PHYS ExitSPROTT PHYSICAL GOLD TRUSTunit$0-2,035,698
-100.0%
-2.40%
INTC ExitINTEL CORPput$0-695,600
-100.0%
-2.82%
AVGO ExitBROADCOM LTDput$0-215,000
-100.0%
-3.99%
CRUS ExitCIRRUS LOGIC INCput$0-755,400
-100.0%
-4.32%
SWKS ExitSKYWORKS SOLUTIONS INCput$0-768,400
-100.0%
-6.29%
GLD ExitSPDR GOLD TRUSTcall$0-1,928,200
-100.0%
-26.04%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MICROSOFT CORP27Q3 20238.7%
BK OF AMERICA CORP24Q3 202315.9%
JPMORGAN CHASE & CO17Q2 20222.2%
MEDIGUS LTD17Q1 20230.0%
WISDOMTREE TR15Q2 20184.0%
RANDGOLD RES LTD15Q2 20183.3%
GRANITE REAL ESTATE INVT TR15Q3 20231.3%
BROOKFIELD ASSET MGMT INC15Q3 20221.3%
CENTRAL FD CDA LTD14Q1 20181.6%
MEI PHARMA INC14Q1 20231.2%

View Anson Funds Management LP's complete holdings history.

Latest significant ownerships (13-D/G)
Anson Funds Management LP Q4 2016 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Appreciate Holdings, Inc.Sold outFebruary 14, 202300.0%
Equity Distribution Acquisition Corp.Sold outFebruary 14, 202300.0%
GO Acquisition Corp.Sold outFebruary 14, 202300.0%
LogicMark, Inc.February 14, 2023987,3999.9%
Model Performance Acquisition CorpSold outFebruary 14, 202300.0%
Mudrick Capital Acquisition Corp. IISold outFebruary 14, 202300.0%
View, Inc.February 14, 202324,597,1859.9%
Amarantus Bioscience Holdings, Inc.April 18, 202214,176,4245.0%
Dune Acquisition CorpFebruary 11, 2022100,0000.6%
PROPTECH INVESTMENT CORP. IIFebruary 11, 20221,184,2765.2%

View Anson Funds Management LP's complete significant-ownership history.

Latest filings
TypeFiled
SC 13D/A2024-04-05
DFAN14A2024-04-04
42024-02-26
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14

View Anson Funds Management LP's complete filings history.

Compare quarters

Export Anson Funds Management LP's holdings